has been cited by the following article(s):
|
[1]
|
Targeting the Key Signaling Pathways in Breast Cancer: From Molecular Mechanism to Therapeutic Interventions
Recent Patents on Anti-Cancer Drug Discovery,
2025
DOI:10.2174/0115748928267931231120065335
|
|
|
|
|
[2]
|
Mini review: The FDA-approved prescription drugs that target the MAPK signaling pathway in women with breast cancer
Breast Disease,
2021
DOI:10.3233/BD-201063
|
|
|
|
|
[3]
|
Signaling pathways governing breast cancer stem cells behavior
Stem Cell Research & Therapy,
2021
DOI:10.1186/s13287-021-02321-w
|
|
|
|